What changed

The U.S. Food and Drug Administration added bemotrizinol to the over-the-counter sunscreen monograph after reviewing a submitted order request and public comments. The final conditions permit use at concentrations up to 6% when the finished product meets the rest of the monograph requirements.

Bemotrizinol has been used in sunscreens in Europe and other markets for years. In the United States, sunscreens are regulated as nonprescription drugs, so a filter cannot simply be imported into a domestic formula because it is accepted elsewhere.

What shoppers should expect

The order opens a regulatory door; it does not set a retail date. Manufacturers decide whether and when to develop, test, label, and distribute compliant products.

A filter name alone cannot tell you how a finished sunscreen will feel or perform. Look for broad-spectrum labeling, an SPF appropriate to your use, water resistance when needed, and a texture you will apply generously and repeat.

The considered take

This is a meaningful regulatory update, not a reason to wait for a future launch before protecting your skin. Existing broad-spectrum sunscreens remain useful when applied correctly alongside shade, clothing, and other sun-protective measures.

Open the source file

These links support the claims above. Source dates, disclosures and limits are documented in the article and source list.

  1. U.S. Food and Drug Administration — final action announcement (opens in a new tab)June 9, 2026
  2. FDA consumer sunscreen guidance (opens in a new tab)